Bridging the gap between biological complexity and clinical clarity through explainable, decision-grade AI.
Founded in 2025, Aveiaa is a drug discovery and development intelligence company with operations in Amman, Jordan and Delaware, USA.
We build decision-grade platforms that help researchers predict development outcomes, reduce risk, and translate scientific complexity into actionable strategy.
Our systems support earlier risk detection, clearer rationale, and faster iteration across the entire R&D lifecycle.
Our mission is to help the world develop superior therapies by transforming complex biomedical evidence into a unified system of explainable intelligence. This journey begins with our Core Databases, which provide clean and structured data layers across chemistry, biology, and clinical evidence. We then elevate this data into Causal Knowledge, creating evidence-linked layers designed to support justified conclusions and strategic clinical insights. Ultimately, this powers our comprehensive Intelligence System, which models development feasibility across efficacy, safety, and clinical outcomes to ensure every discovery reaches its full potential.